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j Abstract Background Normal
weight obesity (NWO) is defined
as an excessive body fat associated
with a normal body mass index
(BMI < 25 kg/m2), but its preva-
lence in the general population is
unknown. Aim of the study To
assess the prevalence of NWO in
Switzerland according to different
cut points used to define excess
body fat. Methods Cross-sectional
study including 3,213 women and
2,912 men aged 35–75 years. Body
fat was assessed by bioelectrical
impedance analysis and preva-
lence of NWO was assessed using
four previously published defini-
tions for excess body fat. Results
Percent body fat increased with
age: in men, the values (mean ±
SD) were 20.2 ± 5.4, 23.0 ± 5.4,
26.3 ± 5.2 and 28.2 ± 4.6 for age
groups 35–44, 45–54, 55–64 and
65–75 years, respectively; the cor-
responding values for women were
29.9 ± 7.8, 33.1 ± 7.4, 36.7 ± 7.5
and 39.6 ± 6.9. In men, prevalence
of NWO was <1% irrespective of
the definition used. Conversely, in
women, a 1- to 20-fold difference
(from 1.4 to 27.8%) in NWO
prevalence was found. The preva-
lence of NWO increased with age
when age-independent cut points
were used in women, but not in
men. Conclusions Prevalence of
NWO is low in the general popu-
lation and higher in women than
in men. The prevalence is highly
dependent on the criteria used to
define excess body fat, namely in
women. The use of gender- and
age-specific cut points to define
excess body fat is better than fixed
or gender-specific only cut points.
j Key words cross-sectional
study – normal weight obesity –
prevalence – Switzerland
ORIGINAL CONTRIBUTION
Eur J Nutr (2008) 47:251–257
DOI 10.1007/s00394-008-0719-6
E
JN
719
The CoLaus study was supported by re-
search grants from GlaxoSmithKline and
from the Faculty of Biology and Medicine
of Lausanne, Switzerland.
P. Marques-Vidal
Cardiomet
CHUV
Lausanne, Switzerland
P. Marques-Vidal (&) Æ F. Paccaud
Institute of Social and Preventive Medicine
(IUMSP)
Centre Hospitalier Universitaire Vaudois
and University of Lausanne
Bugnon 17
1005 Lausanne, Switzerland
Tel.: +41-21/314-7265
Fax: +41-21/314-7373
E-Mail: pedro-manuel.marques-vidal
@chuv.ch
A. Pe´coud
Medical Outpatient Clinic
University of Lausanne
Lausanne, Switzerland
D. Hayoz
Dept. of Medicine
Vascular Medicine, CHUV
Lausanne, Switzerland
V. Mooser
Medical Genetics
GlaxoSmithKline
Philadelphia (PA), USA
G. Waeber Æ P. Vollenweider
Dept. of Medicine
Internal Medicine, CHUV
Lausanne, Switzerland
Introduction
Obesity is defined by an excess body fat [1], but in
the absence of a simple technique to measure body
fat in the general population, increased body mass
index (BMI) has been widely used as a surrogate
marker for excess body fat [1]. Recently, a new en-
tity named normal weight obesity (NWO) has been
described; NWO is defined as a normal BMI asso-
ciated with increased body fat [6] and has been
associated with an unfavorable lipid [6] and
inflammatory [5] profile. Still, the exact prevalence
of NWO in the general population has been seldom
studied. Another difficulty arises as there is no
established validated cut point to define excess body
fat. Body fat levels vary according to gender and age
[6, 11], and several cut points have been proposed to
define excess body fat. For instance, the initial
description of NWO used a single cut point of 30%
to define excess body fat [5, 6], whereas other
authors have proposed gender-specific, age-inde-
pendent [27], or gender- and age-specific [11, 16]
cut points. Further, there is no information regard-
ing the potential effect of those different cut points
on NWO prevalence rates.
Thus, the aim of the present study was to assess the
prevalence of NWO according to those different cut
points in the city of Lausanne, Switzerland.
Subjects and methods
j Sampling
The sampling procedure of the CoLaus (Cohorte
Lausannoise) study has been described previously [8].
Briefly, the complete list of the Lausanne inhabitants
aged 35–75 years (n = 56,694) was provided by the
population registry of the city. A simple, nonstratified
random selection of the subjects was performed and a
random sample of 35% of the overall population was
drawn. An invitation letter with a quick description of
the study and a formulary in a pre-stamped envelope
was sent to all randomized subjects. Subjects inter-
ested in participating returned the formulary and
were contacted telephonically within 14 days by one
of the staff members who provided more information
about the study and arranged for an appointment.
Since the CoLaus study aimed at including only
Caucasians to avoid population stratification and to
increase genetic homogeneity for association studies,
the following inclusion criteria were applied: (a)
written informed consent; (b) aged 35–75 years; (c)
willingness to take part in the examination and to
have blood sample drawn and (d) Caucasian origin.
Caucasian origin was defined as having both parents
and grandparents Caucasian.
Of the initial 19,830 subjects sampled, 54 subjects
were considered as noneligible before contact and
15,109 (76%) responses were obtained. A total of
4,667 subjects who did not respond were considered
as nonresponders. Among responders, 6,189 (41%)
subjects refused to participate in the study and 799
(5%) were considered as noneligible. Subjects who
refused were older (52.6 ± 11.7 vs. 51.2 ± 10.9 years,
P < 0.01) and included more women (61 vs. 52%,
P < 0.01) than subjects who accepted to participate.
The sample of 8,121 subjects who agreed to partici-
pate represented 41% of the initially sampled popu-
lation, 54% of all responders and 57% of all eligible
responders. Among these subjects, the first 6,738 were
invited to attend the clinic and completed the exam-
ination. About 6,189 participants met the inclusion
criteria (including ethnicity) and were included in the
CoLaus study. The other 549 participants (8.1%) were
not of Caucasian ethnicity and were excluded. As the
number of subjects who agreed to participate (8,121)
was higher than the number of subjects initially
planned for the CoLaus study (6,000), 1,383 could not
be included into the study although they were willing
to participate. One subject withdrew after consent due
to personal reasons. Therefore, the final CoLaus
sample (n = 6,188) represents 43% of the eligible
responders, 41% of all the responders and 31% of the
initially sampled population.
j Assessment process
All participants were asked to attend the outpatient
clinic at the Centre Hospitalier Universitaire Vaudois
(CHUV) in the morning after an overnight fast. Data
were collected by trained field interviewers in an
single visit lasting about 60 min. Informed consent
was obtained from participants upon their arrival at
the study clinic. The first questionnaire mailed with
the appointment’s letter and completed by the par-
ticipant prior to the morning visit was then quickly
reviewed and a second questionnaire was applied by
interview prior to clinical measurements and blood
collection.
Data on smoking included the previous and cur-
rent smoking status. Data on alcohol consumption
included the past and current drinking status as well
as the number of alcoholic beverage units (wine, beer
and spirits) consumed over the week preceding the
interview. Data on physical activity assessed whether
the participant practiced leisure time physical activity
at least twice per week. Whenever necessary (difficulty
252 European Journal of Nutrition (2008) Vol. 47, Number 5
 Steinkopff Verlag 2008
in understanding the questionnaire, irrespective of
the reason), staff members helped the participants.
j Clinical data
All staff members were trained and certified before
participating in the study. Certification included
ability to conduct all interviews, to perform phlebot-
omy and blood sample processing, anthropometric
and blood pressure measurements, and data entry.
The data was monitored by an external quality control
organism (PRN, North Hampshire, UK). This external
organism checked the integrity of the data by com-
paring the paper and the electronic information but
had no access to the identification of the participants.
The Ethics Committee was aware of this external data
checking and the letter of consent also included the
information that the data would be checked by an
external organism.
Body weight and height were measured with par-
ticipants standing without shoes in light indoor
clothes. Body weight was measured in kilograms to
the nearest 100 g using a Seca electronic scale
(Hamburg, Germany), which was calibrated yearly.
Height was measured to the nearest 5 mm using a
Seca height gauge (Hamburg, Germany). BMI was
defined as weight/height2. Waist and hip circumfer-
ences were measured as recommended [18].
Body composition was assessed by electrical bio-
electrical impedance analysis [13, 14] using the
Bodystat 1500 analyzer (Isle of Man, British Isles).
This device has been validated against reference
methods [9, 12] and its results have been shown to be
more accurate than those obtained using a dual fre-
quency bioelectrical impedance analysis device [21].
The correlation between the bioelectrical impedance
analysis device and the coefficient of variation for
repeated measurements of electrical impedance is
0.7% [12]; the reproducibility has been shown to be
between 1% [12] and 5% [19]; the intraclass correla-
tion coefficient has been estimated at 0.987 [22] and
its correlation with reference methods such as isotope
dilution is between 0.855 [19] and 0.96 [21]. Subjects
had to fast for at least 5 h, not engage into strenuous
physical activity the previous 12 h and abstain from
consuming caffeine or alcohol-containing beverages
24 h before the analysis. All metallic adornments were
removed, and measurement was performed after a 10-
min rest in the supine position in an air-conditioned
room with a constant temperature of 20C. Care was
taken that the subject did not touch any metallic
component of the bed and that the inner part of the
thighs did not touch each other. The electrodes were
positioned in the right side of the body according to
the manufacturer’s recommendations: injecting leads
were connected to the electrodes behind the finger
and toe, whereas measuring leads were connected to
the electrodes on the wrist and ankle. Measurement
was conducted with a test current of 400 lA (root
mean square) at a frequency of 50 kHz, with an
impedance measuring range of 30–1,000 W (accuracy
3 W). Conversely, no information was available
regarding the equation used (proprietary). Body fat
was expressed as percentage of total body weight
(%BF) or as fat mass index, defined as body fat (in kg)
divided by height (m) squared (kg/m2) [17].
Normal weight obesity was defined as a BMI
< 25 kg/m2 and a % body fat superior to several
established cut points: gender- and age-independent
as reported initially (30% for both men and women)
[5, 6]; fixed sex-specific values (29.1% in men and
37.2% in women) as proposed in NHANES [27]; age-
and gender-specific values derived from an interna-
tional study (for instance, %BF >26% among white
men aged 20–39 or %BF >43% for white women aged
60–79) [11], and age- and gender-specific 95th per-
centiles for the Swiss population (%BF >28.1, 28.7,
30.6 and 32.6% for men aged 35–44, 45–54, 55–64 and
65–74, respectively; the corresponding values for
women being 35.9, 36.5, 40.5 and 44.4%) [16]
(Table 1). Alternatively, normal weight obesity was
also defined as a BMI < 25 kg/m2 and a fat mass
index ‡8.3 kg/m2 (men) or ‡11.8 kg/m2 (women)
[17].
j Statistical analysis
Statistical analyzes were performed using Stata 9.2
(Stata Corp, College Station, USA). Results were ex-
pressed as mean ± standard deviation (SD) or as
number of subjects and (percentage). Comparisons
Table 1 Cut points used to define excess % of body fat
Age group
(years)
De Lorenzo
(%)
NHANES
(%)
Othera
(%)
Switzerlandb
(%)
Men
35–44 30 29.1 26 28.1
45–54 30 29.1 29 28.7
55–64 30 29.1 31 30.6
65–74 30 29.1 32.6
Women
35–44 30 37.2 39 35.9
45–54 30 37.2 41 36.5
55–64 30 37.2 43 40.5
65–74 30 37.2 44.4
The table presents the different cut-points used to define excess body fat by
gender and age group. According to De Lorenzo [5], NHANES [27], other [11]
and Switzerland [16]
aFor white subjects and BMI > 30 kg/m2; age groups are 20–39, 40–59 and
60–79 years
b95th Percentile
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were performed using Student’s t test and analysis of
variance for quantitative variables, and using v2 for
qualitative variables. Statistical significance was as-
sessed for P < 0.05.
Results
j Sample characteristics
Of the 6,188 subjects from the initial sample, 6,125
had data on body fat that allowed their classification.
The other 63 were excluded from the analysis as no
data on body fat was available. Their main clinical
characteristics according to gender are summarized in
Table 2.
Swiss nationals represented circa two thirds of the
sample, and no differences were found between gen-
ders. Six out of 10 subjects reported a current or
previous history of smoking, and slightly more than
half reported engaging in leisure physical activity at
least twice per week. Also, almost three quarters of the
subjects reported some type of alcohol consumption.
Between-gender comparisons showed that women
were older, had a lower educational level, smoked and
drank less and were more physically active than men.
Women also had lower BMI, waist and hip but a
higher % body fat and a higher fat mass index than
men. Finally, in both genders, body fat levels (ex-
pressed in % of body weight) increased with age
(Fig. 1).
j Prevalence of normal weight obesity
The prevalence rates of NWO according to gender,
age group and the cut point used to define excess BF
are summarized in Table 3. In men, prevalence of
NWO was below 1% irrespective of the definition
used, whereas in women a 1- to 20-fold difference in
the prevalence of NWO was found when % body fat
thresholds were used. Conversely, the fat mass index-
based definition led to a very low prevalence of NWO
for both genders (Table 3). In women, the prevalence
of NWO also increased with age when age-indepen-
dent cut points were used, whereas no such increase
with age was found in men. Finally, irrespective of the
definition used, prevalence of NWO was considerably
higher in women than in men, with the exception of
the definition based on fat mass index (Table 3).
Table 2 Sample characteristics, overall and by gender
Overall
(n = 6,125)
Women
(n = 3,213)
Men
(n = 2,912)
P value
Age (years) 53.1 ± 10.8 53.5 ± 10.7 52.6 ± 10.8 0.005
Born in Switzerland
(%)
3,961 (64.7) 2,107 (65.6) 1,854 (63.7) 0.12
Education (%)
Basic 1,273 (20.8) 777 (23.9) 510 (17.4)
Apprenticeship 2,267 (37.0) 1,159 (36.1) 1,108 (38.1) <0.001
High school/college 1,450 (23.7) 792 (24.7) 658 (22.6)
University 1,130 (18.5) 489 (15.2) 641 (22.0)
Smoking status (%)
Current 1,660 (27.1) 804 (25.0) 856 (29.3)
Former 2,015 (32.9) 895 (27.9) 1,130 (38.5) <0.001
Never 2,450 (40.0) 1,514 (47.1) 936 (32.1)
Physical activity (%) 3,400 (55.5) 1,842 (57.3) 1,558 (53.5) 0.005
Alcohol drinking (%) 4,466 (72.9) 2,017 (62.8) 2,449 (84.1) <0.001
Height (cm) 168.6 ± 9.3 162.7 ± 6.7 175.0 ± 7.3 <0.001
Weight (kg) 73.6 ± 15.0 66.4 ± 12.7 81.5 ± 13.1 <0.001
BMI (kg/m2) 25.8 ± 4.5 25.1 ± 4.8 26.6 ± 4.0 <0.001
% Body fat 29.3 ± 8.0 34.3 ± 8.2 23.8 ± 6.0 <0.001
Fat mass index
(kg/m2)
7.8 ± 3.4 8.9 ± 3.7 6.5 ± 2.5 <0.001
Waist (cm) 89.3 ± 13.2 83.4 ± 12.2 95.7 ± 11.1 <0.001
Hip (cm) 101.7 ± 9.2 100.6 ± 10.1 102.9 ± 7.8 <0.001
Results are expressed as number of subjects and (percentage) or as mean ±
standard deviation. Between gender comparisons by v2 or Student’s t test
BMI body mass index
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Fig. 1 Distribution of body fat (expressed as percentage of total body weight)
according to gender and age group. The 30 and 37% thresholds to define
obesity are indicated by the dashed lines
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Discussion
There is little if no information regarding the preva-
lence of NWO in the general population. In this study,
we tried to assess the prevalence of this entity using
several cut points for excess body fat as proposed in
the literature. Since in this study body fat was as-
sessed by bioelectrical impedance analysis, we chose
to use age- and gender-specific bioimpedance-derived
cut points which had been proposed for the Swiss
population [16]; alternatively, other bioimpedance-
derived cut points from an international study [11] or
the USA [27], and the >30% cut-off obtained by DXA
[5] were also used. Overall, our results indicate that in
men the prevalence of NWO was below 1% for all
thresholds used, but that in women the prevalence of
NWO varied considerably from 1.4 to 27.8% accord-
ing to the cut-off used. Interestingly, using age- and
gender-specific cut points [11, 16] led to more similar
results than using a single cut-off [5, 27]. As it has
been shown that body fat increases with age [3, 11,
16], the use of a single cut-off value might overesti-
mate the prevalence of excess fat in the elderly groups
and, inversely, underestimate this condition in the
younger groups. The increase of body fat with age
might also explain the higher prevalence of NWO
when using a single cut-off [5, 27] (see Fig. 1). Finally,
the use of increased fat mass index to define NWO led
to a very low prevalence in both genders; a possible
explanation is the fact that fat mass index is depen-
dent both on the percentage of body fat but also on
the value of BMI (as fat mass index can be derived as
%BF · BMI), and for subjects with a BMI below
25 kg/m2 values of %BF as high as 33% (for men) and
47% (for women) would be needed to reach the
published thresholds [17]; those values are consider-
ably higher than the thresholds used by the other
authors (see Table 1). Hence, it is possible that the
thresholds of fat mass index to define NWO might be
excessive, and further studies are needed to better
assess this point.
This study has some limitations that should be
taken into account. First, only Caucasians were in-
cluded, and it might be necessary to use ethnic-spe-
cific cut-points as proposed by others [3, 7, 27].
Second, the assessment of body fat was performed
using bioelectrical impedance analysis, which might
underestimate the values relative to DXA [20, 25],
although this statement has been challenged [2, 4],
namely among normal weight subjects [23]. Thus, it is
rather unlikely that the high prevalence of women
with NWO observed in this study using cut points
obtained by DXA [5, 6] was due to an underestima-
tion of body fat by bioelectrical impedance analysis.
Third, our study did not include subjects aged over
75 years, and it would have been interesting to assess
the prevalence of NWO in this age group. Still, the
results obtained among participants aged 65–75 years
indicate that the prevalence of NWO varies consid-
erably depending on the definition used, and that age-
specific cut-points to define excess body fat might be
necessary, although further studies are needed to
better assess this point. Fourth, the participation rate
was rather low (41%), which might limit the gener-
alization of our findings. However, low participation
is typical of surveys in Western countries and is
comparable with the MONICA surveys conducted in
Switzerland and in other countries [26]. The magni-
tude of the nonparticipation bias is not proportional
to the percentage of nonparticipants [10] and a study
on representativeness observed that people with risky
behaviors participated in the same proportions as
people without risk factors [24]. Finally, it has been
shown that the NHANES and Geneva bioelectrical
impedance analysis equations estimate body compo-
sition equally well in men but showed some discrep-
ancies in women [15]; thus, it is likely that the
differences in the prevalence of NWO women as de-
rived from the Swiss or the USA cut points might
partly be due to differences in estimation methods.
In summary, our data indicate that prevalence of
NWO is low in the Caucasian population of Lausanne
and higher in women than in men. Our results also
indicate that the prevalence of NWO in women is
highly dependent on the cut point used to define ex-
Table 3 Prevalence of normal weight obesity by gender and age group
according to the cut-point used to define excess body fat
Age group n De Lorenzoa NHANESb Otherc Switzerlandd Fat mass
indexe
Men
All 2,912 21 (0.7) 29 (1.0) 24 (0.8) 17 (0.6) 1 (0.1)
35–44 873 2 (0.2) 3 (0.3) 3 (0.3) 3 (0.3) 0 (0.0)
45–54 840 4 (0.5) 5 (0.6) 6 (0.7) 6 (0.7) 0 (0.0)
55–64 760 4 (0.5) 5 (0.7) 6 (0.8) 3 (0.4) 0 (0.0)
65-75 439 11 (2.5) 16 (3.6) 9 (2.1) 5 (1.1) 1 (0.2)
Women
All 3,213 892 (27.8) 222 (6.9) 44 (1.4) 80 (2.5) 2 (0.1)
35–44 857 128 (14.9) 9 (1.1) 6 (0.7) 17 (2.0) 0 (0.0)
45–54 906 229 (25.3) 29 (3.2) 6 (0.7) 35 (3.9) 1 (0.1)
55–64 932 322 (34.6) 75 (8.1) 11 (1.2) 18 (1.9) 0 (0.0)
65-75 518 213 (41.1) 109 (21.0) 21 (4.1) 10 (1.9) 1 (0.2)
Results are expressed as number of subjects and (percentage). Definitions used:
BMI < 25 kg/m2
aGender- and age-independent (30% for both men and women) [5, 6]
bFixed sex-specific values (29.1% in men and 37.2% in women) [27]
cAge- and gender-specific values (%BF >26% among white men aged 20–
39 years or %BF >43% for white women aged 60–79 years) [11]
dAge- and gender-specific 95th percentiles for the Swiss population (%BF
>28.1, 28.7, 30.6 and 32.6% for men aged 35–44, 45–54, 55–64 and 65–
74 years, respectively; the corresponding values for women being 35.9, 36.5,
40.5 and 44.4%) [16]
eFat mass index ‡8.3 kg/m2 (men) or ‡11.8 kg/m2 (women) [17]
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cess body fat, and efforts are needed to establish
appropriate body fat cut points if the prevalences are
to be compared between surveys.
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